The Fructoasamine Test For Diabetes Testing

by Cindy

The Fructosamine Test For Diabetes Testing

Most diabetic patients are familiar with the most commonly used hemoglobin a1c blood test that is used to monitor blood sugar readings over several months.  The fructoasmine test is another type of blood test that has been used in diabetes testing to monitor glucose levels.  This test used less frequently than the a1c test but it still has a place in diabetic management.

What are the Benefits of Fructosamine Diabetes Testing?

The fructosamine test is a type of diabetes testing that is used to measure average blood sugar control over a shorter time span than the hemoglobin a1c.  The fructosamine test can monitor changes in glucose control over 2-3 weeks as compared to the 2-3 months that is measured by the hemoglobin a1c test.  Like the hemoglobin a1c blood test, this type of testing is done using a simple blood test.

Frucotosamine diabetes testing is commonly used for many different reasons.  Since this type of diabetes testing measures changes in glycemic control over a shorter interval, it is helpful for monitoring the response to changes in treatment plans.  This test also can be used in patients with certain health conditions that may cause inaccurate hemoglobin a1c results. This type of diabetes testing can also be used in pregnant women to monitor the overall blood sugar control during the pregnancy.

The fructoasmine test is also available for testing at home using a special kit.  This type of testing may be used weekly for patients who cannot or refuse to measure daily fingerstick readings with a glucometer.  This type of monitoring is inferior to daily glucose monitoring because it will only measure an average glucose and will not show how sugar levels are influenced by meals.  Home diabetes testing using the fructosamine levels should be reserved for only extreme cases where home monitoring using a glucometer is not possible.

The fructosamine test is infrequently used in clinical practice and current guidelines from the American Diabetes Association do not promote the use of this test for routine monitoring.  However for certain patient populations, this form of glycemic monitoring may have a place.

Previous post:

Next post: